Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2025-12-30 @ 10:18 PM
Study NCT ID:
NCT06922604
Status:
RECRUITING
Last Update Posted:
2025-11-07
First Post:
2025-04-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma
Sponsor:
City of Hope Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-30
Start Date Type:
ACTUAL
Primary Completion Date:
2029-01-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-01-02
Completion Date Type:
ESTIMATED
First Submit Date:
2025-04-03
First Submit QC Date:
None
Study First Post Date:
2025-04-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-06
Last Update Post Date:
2025-11-07
Last Update Post Date Type:
ESTIMATED